Early research (Phase 1)Study completedNCT05504317What this trial is testingAK111 in Subjects With Moderate-to-severe Plaque PsoriasisWho this might be right forPsoriasis Akeso 48
Large-scale testing (Phase 3)WithdrawnNCT01936688What this trial is testingEvaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)Who this might be right forPlaque-type Psoriasis Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT01970488What this trial is testingStudy to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Amgen 350
Large-scale testing (Phase 3)Study completedNCT02932462What this trial is testingStudy to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp PsoriasisWho this might be right forScalp Psoriasis Sun Pharmaceutical Industries, Inc. 373
Testing effectiveness (Phase 2)Study completedNCT04612699What this trial is testingJaktinib in Participants With Moderate to Severe PsoriasisWho this might be right forModerate-to-Severe Plaque Psoriasis Suzhou Zelgen Biopharmaceuticals Co.,Ltd 123
Large-scale testing (Phase 3)Study completedNCT03536884What this trial is testingEvaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque Psoriasis UCB Biopharma SRL 743
Post-approval studies (Phase 4)UnknownNCT01228409What this trial is testingLow-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?Who this might be right forPsoriasis Frankel, Amylynne, M.D. 20
Post-approval studies (Phase 4)Ended earlyNCT00697593What this trial is testingChangE From Any Systemic psoriasiS therapY to RaptivaWho this might be right forChronic Plaque Psoriasis Merck KGaA, Darmstadt, Germany 70
Large-scale testing (Phase 3)Study completedNCT06586112What this trial is testingEvaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Alumis Inc 912
Large-scale testing (Phase 3)Study completedNCT01646177What this trial is testingA Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)Who this might be right forPsoriasis Eli Lilly and Company 1,346
Not applicableStudy completedNCT02954081What this trial is testingAPremilast After FumaRic Acid Ester TreatmentWho this might be right forPsoriasis Amgen 687
Large-scale testing (Phase 3)Looking for participantsNCT07250802What this trial is testingA Long-Term Study of Zasocitinib in Children and Teenagers With Plaque PsoriasisWho this might be right forPlaque Psoriasis Takeda 110
Large-scale testing (Phase 3)Study completedNCT00747344What this trial is testingTrial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type PsoriasisWho this might be right forPsoriasis Centocor, Inc. 121
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07158268What this trial is testingHSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Haisco Pharmaceutical Group Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT04036435What this trial is testingLong-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 1,466
Large-scale testing (Phase 3)UnknownNCT06299982What this trial is testingAn Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsOWho this might be right forPlaque Psoriasis Patients Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Post-approval studies (Phase 4)Not Yet RecruitingNCT07529925What this trial is testingA Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque PsoriasisWho this might be right forSevere Plaque Psoriasis in Chinese Children Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 30
Large-scale testing (Phase 3)Study completedNCT01206660What this trial is testingEffects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasis Sun Pharmaceutical Industries, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00725348What this trial is testingAn Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type PsoriasisWho this might be right forPsoriasis Stiefel, a GSK Company 19
Post-approval studies (Phase 4)Study completedNCT06329258What this trial is testingCombination of Sotyktu and Enstilar for Plaque PsoriasisWho this might be right forPsoriasis Psoriasis Treatment Center of Central New Jersey 30